Penn Medicine Abramson Cancer Center
Update on Patient Care Treatment Strategies in Leukemia
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Medicine Updates on Blood/Marrow Transplantation & Cellular Therapy for Anemia & Thrombocytopenia: Does TXA Decrease the Bleeding Rate? Can We Achieve TI With Roxadustat? How Do ASCT Patients Respond to Vaccinations?
FEATURING
Patricia A. Ford
- 132 views
- March 3, 2021
- 1
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn Expert Discussion on MDS, MPN & Leukemia: Transfusion-Dependent MDS Patients, Patients Treated With Hydroxyurea for MPN, AML Pts to Treat With Ven + HMAs, Oral HMAs, Maintenance Azacitidine
FEATURING
Keith Pratz,
Shannon McCurdy,
Daria V. Babushok,
Alexander Perl,
Selina Luger,
Sunil Saroha
- 23 views
- March 3, 2021
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
2021 Penn Medicine Update on FLT3i in R/R AML: Gilteritinib Mono and in Combination With Venetoclax, Newer Agents in Frontline Intensive Therapy and Post-transplant Maintenance
FEATURING
Alexander Perl
- 123 views
- March 2, 2021
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Update on MPNs: Does PTG-300 Eliminate the Need for Therapeutic Phlebotomy in PV? Is Imetelstat Active in R/R MF? What Is the Role of BETi as an "Add On" to Ruxolitinib in MF?
FEATURING
Daria V. Babushok
- 75 views
- March 2, 2021
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Updates on CML: Do Cancer-Related Mutational Events at Diagnosis Predict Inferior Outcomes? Is Ponatinib Effective & Safe? Is Asciminib More Beneficial vs. Bosutinib in CP-CML Treated With > TKIs?
FEATURING
Daria V. Babushok
- 202 views
- March 2, 2021
- 2
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Penn Update on Novel Therapies for Higher Risk MDS: What Is the Role of Pevonedistat & Sabatolimab? Is Venetoclax an Option? Should We Consider Magrolimab? Is Enasidenib Effective in IDH2 MDS?
FEATURING
Shannon McCurdy
- 242 views
- March 2, 2021
- 2